News
Berrys Vistop Meets Growing Sustainability and Sterilization Demands
Following the International Sustainability and Carbon Certificate (ISCC) Plus accreditation of its Berry Astra Plastique facility in Saint-Georges-de-Reneins, France, Berry Healthcare’s market-leading Vistop® PP36 patented tamper evident closure for autoclave sterilisation can now be specified incorporating advanced recycling resin...
News
Genezen Appoints New CEO as GMP Expansion Begins
Genezen Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has appointed Ray Kaczmarek as CEO.
Mr. Kaczmarek has over 28 years of leadership experience with the past 20 years in pharmaceutical and biotechnology manufacturing and supply...
News
CEVEC and UCB sign agreement for the use of CEVEC’S ELEVECTA AAV manufacturing technology in Gene Therapy
CEVEC Pharmaceuticals GmbH announced the signing of an agreement with UCB S.A. on the evaluation and use of CEVEC’s proprietary ELEVECTA® Technology for the research, development, and manufacturing of Adeno-Associated Virus (AAV) vectors for gene therapy applications.
According to the...
Drug Research
Arecor Therapeutics Signs Formulation Agreement with Intas Pharmaceuticals
Arecor Therapeutics plc, a biopharmaceutical group advancing therapies to enable healthier lives, has signed a formulation agreement with Intas Pharmaceuticals Ltd.
Under this agreement, Arecor will use its proprietary formulation technology platform Arestat to develop a differentiated product for Intas....
News
DoKaSch Temperature Solution opens new service station in India
DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal.
Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s...
News
Hetero obtains DCGI approval to produce Roche’s Covid-19 drug in India
Indian drug developer Hetero said it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's (ROG.S) COVID-19 drug.
Hetero expects to make the treatment, tocilizumab, available in India by the...
Clinical Trials
Reliance obtains DCGI approval to conduct Phase I Covid-19 vaccine trial
Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I clinical trial of its Covid-19 vaccine with some conditions.
This trial will assess the safety, tolerability and immunogenicity of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















